We are live on
!
Find out more
B
Bellecapital Portfolio holdings
AUM
$625M
Turnover
41.45%
1-Year Est. Return
39.69%
This Fund
S&P 500
This Quarter
Est. Return
+7.59%
1 Year Est. Return
+39.69%
3 Year Est. Return
+127.77%
5 Year Est. Return
+155.51%
10 Year Est. Return
+530.96%
AUM
$153M
AUM Growth
+$14M
(+10%)
Cap. Flow
+$5.17M
Cap. Flow
% of AUM
3.39%
Top 10 Holdings %
Top 10 Hldgs %
43.38%
Holding
102
New
13
Increased
21
Reduced
25
Closed
17
Avg Time Held
1.5
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$6.13M |
| 2 |
Salesforce
CRM
|
+$2.21M |
| 3 |
Hello Group
MOMO
|
+$2.19M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$966K |
| 5 |
Weibo
WB
|
+$853K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$3.48M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$833K |
| 3 |
iShares Currency Hedged MSCI Japan ETF
HEWJ
|
+$677K |
| 4 |
State Street SPDR S&P China ETF
GXC
|
+$545K |
| 5 |
iShares Preferred and Income Securities ETF
PFF
|
+$545K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 25.09% |
| 2 | Consumer Discretionary | 14.83% |
| 3 | Technology | 14.32% |
| 4 | Healthcare | 13.09% |
| 5 | Communication Services | 11.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
iShares MSCI EAFE ETF
EFA
$77.5B
| $524K | 0.34% |
+7,704
| New | +$520K |
2018 Q3
0 quarters
|
|
52
Alphabet (Google) Class C
GOOG
$4.16T
| $517K | 0.34% |
8,660
-520
| -6% | -$31.1K |
2016 Q2
9 quarters
|
|
|
ABB
53
DELISTED
ABB Ltd
ABB
| $505K | 0.33% |
21,365
| – | – |
2016 Q4
7 quarters
|
|
54
Intel
INTC
$484B
| $503K | 0.33% |
10,626
+1,266
| +14% | +$61.6K |
2017 Q1
6 quarters
|
|
55
Procter & Gamble
PG
$371B
| $499K | 0.33% |
6,000
+310
| +5% | +$25.4K |
2013 Q4
19 quarters
|
|
|
RDS.A
56
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $494K | 0.32% |
7,251
| – | – |
2016 Q3
8 quarters
|
|
57
iShare MSCI Eurozone ETF
EZU
$9.32B
| $475K | 0.31% |
+11,581
| New | +$480K |
2018 Q3
0 quarters
|
|
58
UBS Group
UBS
$148B
| $462K | 0.3% |
29,402
+275
| +0.9% | +$4.32K |
2018 Q1
2 quarters
|
|
|
IBDL
59
DELISTED
iShares iBonds Dec 2020 Term Corporate ETF
IBDL
| $415K | 0.27% |
16,580
| – | – |
2017 Q4
3 quarters
|
|
60
Johnson & Johnson
JNJ
$620B
| $414K | 0.27% |
2,994
+100
| +3% | +$13.3K |
2018 Q1
2 quarters
|
|
61
iShares MSCI United Kingdom ETF
EWU
$3.81B
| $409K | 0.27% |
12,000
| – | – |
2017 Q2
5 quarters
|
|
62
DELISTED
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
| $404K | 0.26% |
16,615
| – | – |
2017 Q4
3 quarters
|
|
63
Boeing
BA
$151B
| $380K | 0.25% |
1,023
| – | – |
2017 Q4
3 quarters
|
|
64
Novartis
NVS
$288B
| $367K | 0.24% |
4,755
+409
| +9% | +$30.2K |
2017 Q1
6 quarters
|
|
65
Teva Pharmaceutical Industries Limited
TEVA
$48.3B
| $345K | 0.23% |
16,000
| – | – |
2018 Q2
1 quarter
|
|
66
Banco Santander
SAN
$196B
| $340K | 0.22% |
71,003
+9,957
| +16% | +$50.1K |
2017 Q3
4 quarters
|
|
67
Meta Platforms (Facebook)
META
$1.84T
| $334K | 0.22% |
2,028
+70
| +4% | +$12.7K |
2018 Q1
2 quarters
|
|
68
JPMorgan Chase
JPM
$914B
| $324K | 0.21% |
2,871
| – | – |
2014 Q3
16 quarters
|
|
69
Berkshire Hathaway Class A
BRK.A
$1.14T
| $320K | 0.21% |
1
| – | – |
2017 Q4
3 quarters
|
|
70
Eli Lilly
LLY
$1.13T
| $279K | 0.18% |
2,602
| – | – |
2017 Q4
3 quarters
|
|
71
Vanguard Short-Term Corporate Bond ETF
VCSH
$44B
| $275K | 0.18% |
3,520
+390
| +12% | +$30.5K |
2016 Q4
7 quarters
|
|
|
AXJL
72
DELISTED
WisdomTree Asia-Pacific ex-Japan Fund
AXJL
| $271K | 0.18% |
4,004
| – | – |
2018 Q2
1 quarter
|
|
73
iShares 1-3 Year Treasury Bond ETF
SHY
$26.9B
| $270K | 0.18% |
+3,253
| New | +$271K |
2018 Q3
0 quarters
|
|
74
iShares 7-10 Year Treasury Bond ETF
IEF
$41.8B
| $269K | 0.18% |
+2,659
| New | +$271K |
2018 Q3
0 quarters
|
|
75
iShares MSCI Switzerland ETF
EWL
$2.85B
| $249K | 0.16% |
+7,188
| New | +$246K |
2018 Q3
0 quarters
|
|
Similar funds
TAM
RIP
LWP
FGA
BVC
APM
PIM
PAS
Bellecapital's Q3 2018 Portfolio in Review
As of Q3 2018, Bellecapital held 102 positions worth $153M, up 10% from $138M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Bellecapital deployed $5.17M of net new capital in Q3 2018, opening 13 new positions and adding to 21 existing holdings. Its largest new stake was Salesforce: 14,895 shares worth $2.37M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 27% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was iShares Biotechnology ETF, an estimated $833K trimmed.
- Bellecapital's largest Q3 2018 buy was Salesforce: 14,895 shares worth $2.37M.
- Bellecapital added most to Coca-Cola in Q3 2018, an estimated $6.13M increase.
- Bellecapital's biggest Q3 2018 reduction was iShares Biotechnology ETF, cutting an estimated $833K.
- Bellecapital fully exited SLB Ltd in Q3 2018, selling an estimated $3.48M.
- Bellecapital's ten largest holdings make up 43% of its $153M portfolio in Q3 2018.
- Bellecapital opened 13 new positions and closed 17 in Q3 2018.
- Bellecapital's portfolio value rose 10% quarter-over-quarter to $153M.
Based on Bellecapital's 13F filing for Q3 2018, filed 12 Oct 2018.